Prime presents at AMCP Nexus 2023 on Oct. 16–19 - Prime Therapeutics
Prime presents at AMCP Nexus 2023 on Oct. 16–19
Event features Prime experts who will discuss hottest health care topics
Event/registration:
AMCP Nexus 2023
Educational sessions:
“Medically Integrated Dispensing Services: Creative Value for Payers and Providers”
Date/time: Tuesday, October 17 | 7:30–8:45 a.m. CT
Prime participants: Ben Urick, health outcomes research principal, Prime Therapeutics; Kyle Verley, director of network management, Prime Therapeutics
“Rare Disease Spotlight: Hereditary Angioedema Treatment Advances, Patient Value, and Access to Care”
Date/time: Tuesday, October 17 | 7:30–8:45 a.m. CT
Prime participants: Sneha Sharma, director, medical pharmacy strategy, Magellan Rx Management
“Improving Treatment Access for Spinal Muscular Atrophy: How Managed Care Strategies Can Ease Clinical and Caregiver Burden”
Date/time: Tuesday, October 17 | 10:30–12:30 p.m. CT
Prime participants: YuQian Liu, senior director, clinical account services, Magellan Rx Management
“Managed Care Oncology Perspectives: CAR T-cells vs BiTEs”
Date/time: Tuesday, October 17 | 2:15–3:30 p.m. CT
Prime participants: Michelle Pannone-Booth, senior director, account services, Magellan Rx Management; Simone Ndujiuba, product development, director of clinical oncology, Magellan Rx Management
“Award-winning Research Supporting the Managed Care Pharmacy Agenda”
Date/time: Tuesday, October 17 | 2:15–3:30 p.m. CT
Prime participants: Nicholas Friedlander, clinical program pharmacist, Prime Therapeutics
“Biosimilar Operational Readiness: Managed Care Stakeholder Response to Market Expansion Impact”
Date/time: Wednesday, October 18 | 8:45–10:00 a.m. CT
Prime participants: Prerak Parikh, director, medical pharmacy strategy, Magellan Rx Management
“Navigating NASH: A Discussion on Clinical Background, Patient Advocacy and Managed Care Considerations”
Date/time: Wednesday, October 18 | 8:45–10:00 a.m. CT
Prime participants: Brian MacDonald, senior director, clinical project and program management, Magellan Rx
“Gene Therapies: Forecasting Potential Candidates Using Medical Pharmacy Claims Data”
Date/time: Wednesday, October 18 | 3:30–4:45 p.m. CT
Prime participants: Pat Gleason, AVP of health outcomes, Prime Therapeutics
About Prime Therapeutics
Prime Therapeutics LLC (Prime) is a diversified pharmacy solutions organization. We offer innovative pharmacy benefit management, specialty and medical drug management, and state government solutions to millions of people across the country. At Prime, we’re reimagining pharmacy solutions to provide the care we’d want for our loved ones. We challenge the way it’s always been done to develop intelligently designed solutions that deliver savings, simplicity and support to help people achieve better health. For more information, visit us at PrimeTherapeutics.com or follow us on LinkedIn.